EcoDrugPlus

Catechol-O-Methyltransferase

Ensembl ID : ENSSARG00000014022
Gene Symbol: COMT
3 External references
275 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSSARG00000010280
Gene Symbol: CTSC
3 External references
233 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSSARG00000005478
Gene Symbol: CTSK
1 External references
240 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSSARG00000007105
Gene Symbol: CDC7
1 External references
208 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSSARG00000004738
Gene Symbol: CHEK1
1 External references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSSARG00000001459
Gene Symbol: CHEK2
1 External references
205 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSSARG00000000918
Gene Symbol: CCKBR
1 External references
264 Possible Orthologues:

Cholinergic Receptor Muscarinic 1

Ensembl ID : ENSSARG00000011095
Gene Symbol: CHRM1
1 External references
101 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSSARG00000005539
Gene Symbol: CHRNA3
1 External references
207 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 4 Subunit

Ensembl ID : ENSSARG00000008070
Gene Symbol: CHRNA4
1 External references
204 Possible Orthologues:

Chymase 1

Ensembl ID : ENSSARG00000003510
Gene Symbol: CMA1
3 External references
292 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSSARG00000013083
Gene Symbol: F2R
3 External references
327 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).